These data suggest that the interaction between TIGIT on activated memory B cells and CD155 on activated Tfh cells is a negative feedback mechanism to suppress the proliferation of Tfh cells, independent of IL-10 production, and that this feedback mechanism is impaired by dysregulation of the CD40/TCF4/TIGIT axis in patients with MS. Here, TCF4 is linked to myeloid sarcoma.